34 results
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
14 Feb 24
Interim condensed consolidated financial statements of
7:30am
shareholders to assert a material influence over the Company’s operations and governance;
the adverse impact of factors outside our control
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
14 Nov 23
Interim condensed consolidated financial statements of
12:00am
and governance;
the adverse impact of factors outside our control, such as global health pandemics, natural disasters, geopolitical conflict and macroeconomic
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
28 Aug 23
Current report (foreign)
4:49pm
Member of the Audit Committee.
Member of the Compensation Committee.
Member of the Corporate Governance and Nominating Committee.
Lead Director … . Sampson has served on multiple Scientific and Governance Boards in publicly traded biotechnology companies along with major non-profit health delivery
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
28 Jul 23
Interim condensed consolidated financial statements of
8:31am
shareholders to assert a material influence over the Company’s operations and governance;
the adverse impact of factors outside our control, such as global
6-K
EX-99.2
zy0p066
4 Nov 22
Interim condensed consolidated financial statements of
8:00am
6-K
EX-99.1
who5zr47
22 Aug 22
Current report (foreign)
11:39am
6-K
EX-99.2
z21wn4th
15 Aug 22
Interim Condensed Consolidated Statements of Financial Position
8:00am
SUPPL
zv8rt5a8qlj5sac
10 Aug 22
Supplemental materials (foreign)
3:10pm
SUPPL
56lhw7958fu o7ulutb
8 Aug 22
Supplemental materials (foreign)
8:40pm
20-F
EX-15.2
0prx6jtufq9u1xp zr9
22 Jun 22
Annual report (foreign)
5:04pm
20-F
cll4a3g2xlmcul25yce2
22 Jun 22
Annual report (foreign)
5:04pm
20-F
EX-15.1
0eazvu2c8sejzdb7ag9
22 Jun 22
Annual report (foreign)
5:04pm
6-K
EX-99.3
vy6e3352rj6mr k0
22 Jun 22
Current report (foreign)
8:00am
6-K
EX-99.1
9criob49
22 Jun 22
Current report (foreign)
8:00am
6-K
EX-99.2
88b9nruykselq73j3
9 Feb 22
Interim condensed consolidated financial statements of
7:18am
6-K
EX-99.2
v0y58ny3ny61er7aacwn
12 Nov 21
Interim condensed consolidated financial statements of
7:15am
6-K
EX-99.1
d4c6p9s1gj1c az4veq7
23 Sep 21
Medicenna Appoints Dr. John H. Sampson to its Board of Directors
5:28pm
6-K
EX-99.1
qomwfk
1 Sep 21
Current report (foreign)
8:00am